Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 67-72

  Winkler, Gábor ^a,b   Hidvégi, Tibor ^c   Vándorfi, Gyozo ^d   Balogh, Sándor ^e   Jermendy, György ^f  

^a ST JOHN'S HOSPITAL   (Hungary)

^b UNIVERSITY OF MISKOLC   (Hungary)

^c Petz County Teaching Hospital   (Hungary)

^d Department of Radiology   (Hungary)

^e National Institute of Primary Health Care   (Hungary)

^f BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

Author keywords

Diabetes screening; FINDRISC questionnaire; Glucose intolerance; Oral glucose tolerance test; Type 2 diabetes

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; GLUCOSE INTOLERANCE; HIGH RISK POPULATION; HUMAN; HUNGARY; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; QUESTIONNAIRE; RISK; SCORING SYSTEM; SCREENING;

EID: 84876880863     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883747     Document Type: Article

References (26)

1. Amos AF, McCarty DJ, Zimmet P: The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med, 1997; 14(Suppl.5): S1-S85
2. Wild S, Roglic G, Green A et al: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2003; 27: 1047-53
3. P: The burden of type 2 diabetes: are we doing enough? Diabetes Metab, 2003; 29: 6S9-6S18
4. Holman RR, Paul SK, Bethel MA et al: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008; 359: 1577-89
5. Skyler JS, Bergenstal R, Bonow RO et al: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE and VA Diabetes Trials. A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care, 2009; 32: 187-92
6. WHO Study Group: Diabetes mellitus. Technical report series 727. WHO, Geneva, 1985.
7. Lindström J, Tuomilehto J: The diabetes risk score. A practical tool to predict diabetes risk. Diabetes Care, 2003; 26: 725-31
8. WHO/IDF: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. NLM classification: WK 810 (ISBN 975 92 4 159493 6) WHO, Brussels, 2006
9. Vamos EP, Kopp MS, Keszei A et al: Prevalence of diabetes in a large, nationally representative population sample in Hungary. Diabetes Res Clin Pract, 2008; 81: e5-8
10. Jermendy G, Nádas J, Szigethy E et al: Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people ages 20-69 years. Croat Med J, 2010; 51: 151-56
11. Health Science Research Institute Hungarian Statistical Office, www.demografia.hu/adatb.html access: 30. 09. 2011
12. Gyürüs É, Green A, Patterson CC, Soltész G: Hungarian Childhood Diabetes Epidemiology Study Group. Dynamic changes in the trends in incidence of type 1 diabetes in children in Hungary (1978-98). Pediatr Diab, 2002; 3: 194-99
13. Schwarz PEH, Li J, Reimann M et al: The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards Type 2 diabetes. J Clin Endocrinol Metab, 2009; 94: 920-26
14. Makrilakis K, Liatis S, Grammatikou S et al: Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab, 2011; 37: 144-51
15. Tankova T, Chakarova N, Atanasova I, Dakovska L: Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diab Res Clin Pract, 2011; 92: 46-52
16. Saaristo T, Moilanen L, Korpi-Hyövälti E et al: Lifestyle intervention for prevention of Type 2 diabetes in primary health care. One year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care, 2010; 33: 2146-51
17. The Diabetes Prevention Program Research Group. Strategies to identify adults at high risk for Type 2 diabetes. Diabetes Care, 2005; 28: 150-56
18. Wang J, Stancáková A, Kuusisto J, Laakso M: Identification of undiagnosedType 2 diabetic individuals by the Finish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish man. J Clin Endocrinol Metab, 2010; 95: 3858-62
19. Alssema M, Vistisen D, Heymans MW et al: The evaluation of screening and early detection strategies for type 2 diabetes and impaired glucose tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia, 2011; 54: 1004-12
20. Bergmann A, Li J, Wang L et al: A simplified Finnish diabetes risk score to predict Type 2 diabetes risk and disease evolution in a German population. Horm Metab Res, 2007; 39: 677-82
21. Li J, Bergmann A, Reimann M et al: A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed Type 2 diabetes in a German population with a family history of the metabolic syndrome. Horm Metab Res, 2009; 41: 98-103
22. Dunstan DW, Zimmet PZ, Welborn TA et al: The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care, 2002; 25: 829-34
23. Bartnik M, Rydén L, Malmberg K et al: Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart, 2007; 93: 72-77
24. Schwarz PE, Li J, Lindstrom J, Tuomilehto J: Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res, 2009; 41: 86-97
25. Alberti KG, Zimmet P, Shaw J: International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med, 2007; 24: 451-63
26. Paulweber B, Valensi P, Lindström J et al: A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res, 2010; 42(Suppl.1): S3-S36